Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Evaluating Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

NCT06022159 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.

NCT NCT06022159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06022159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Evaluating Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.
Lead sponsor
Institut Claudius Regaud
Phase
Phase 2
Overall status
Recruiting
Start date
November 28, 2023
Completion date
May 31, 2029
Enrollment
48 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma